ALD-301, bone marrow-derived cells for critical limb ischemia

ALD products are bone marrow-derived cells which express high levels of aldehyde dehydrogenase (ALDH). These cells are used to treat critical limb ischemia. The treatment improved blood flow and clinical status. The therapy appears to be safe, without significant side effects or adverse events.